Skip to content

Comparing the effectiveness of intrapleural alteplase injection with intrapleural normal saline injection

comparing the efficacy of intrapleural injection of alteplase with intrapleural infusion of normal saline through a chest tube in patients with parapneumonic effusion requiring drainage referred to Akbar Hospital

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250507065631N1
Enrollment
30
Registered
2025-08-02
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abscess of lung and mediastinum. Abscess of lung and mediastinum

Interventions

Intervention 1: Intervention group: In patients in the intervention group, plasminogen (TPA), produced by Samen Pharmaceutical Company, will be injected into the pleural space at a dose of 0.1 mg per

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Presence of pneumonia Pleural effusion

Exclusion criteria

Exclusion criteria: Evidence of bleeding or bleeding disorder Pneumothorax Persistent leak from chest tube site Evidence of bronchopleural fistula Evidence of fibrinous septa and loculation on ultrasound or pleural paracentesis results with any of the following: lactate dehydrogenase greater than 1000, glucose less than 40, Gram stain fails to identify organism, frank pus

Design outcomes

Primary

MeasureTime frame
Recovery. Timepoint: After the intervention is completed. Method of measurement: Monitoring vital signs with a vital signs monitor, thermometer, blood pressure monitor, and pulse oximeter.

Secondary

MeasureTime frame
Erythrocyte sedimentation rate. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Erythrocyte sedimentation rate test.;CRP (C-reactive protein) test. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: It is performed using nephelometric or turbidometric methods in automated laboratory devices.;CBC diff test (complete blood count with differential). Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Blood cell counting is performed using automated machines.;Need for thoracotomy (open surgery) orminimally invasive surgery. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Imaging.;Fever. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Thermometer.;Respiratory distress. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Stopwatch.;Oxygen level. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Pulse oximetry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisan Omidvar

Mashhad University of Medical Sciences

pari.san68124@gmail.com+98 51 3871 3801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026